U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT07469098) titled 'Group vs Individual MDMA-Assisted Therapy for PTSD After the October 7, 2023 Events' on Feb. 10.
Brief Summary: The goal of this clinical trial is to evaluate the safety, tolerability and effectiveness of group-based MDMA-assisted therapy compared to individual MDMA-assisted therapy in participants with PTSD, who were diagnosed following the events of 7 October 2023. The main questions it aims to answer are: safety and tolerability? effectiveness? Researchers will compare group-based MDMA-assisted therapy to individual MDMA-assisted therapy to see if group-based MDMA-assisted therapy is not inferior to individual MDMA-assisted ther...